• Corpus ID: 27501901

2 Prevention of Type 2 Diabetes

  title={2 Prevention of Type 2 Diabetes},
  author={Jonathan E. Shaw and Richard W. Simpson},
The numbers of people with type 2 diabetes are rising rapidly around the world, making it imperative to develop and introduce methods of preventing the condition. A series of clinical trials over the last decade has shown conclusively that lifestyle interventions focusing on physical activity, diet, and weight loss can reduce the risk of developing type 2 diabetes by approximately 60%. Trials examining pharmaceutical interventions have shown that metformin, acarbose, and glitazones also reduce… 

Figures and Tables from this paper


Lifestyle intervention to prevent diabetes: intensive AND cost effective
Lifestyle intervention needs to incorporate individualization and repeated long-term contacts with trained facilitators to prevent diabetes and hence its complications from developing.
Ramipril and the development of diabetes.
Ramipril is associated with lower rates of new diagnosis of diabetes in high-risk individuals and these effects were also consistently seen in several subgroups examined.
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk and the lifestyle intervention was more effective than meetformin.
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
Troglitazone markedly reduced the incidence of diabetes during its limited period of use, but this action did not persist, and whether other thiazolidinedione drugs used for longer periods can safely prevent diabetes remains to be determined.
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.
Compared with lifestyle changes alone, orlistat plus lifestyle changes resulted in a greater reduction in the incidence of type 2 diabetes over 4 years and produced greater weight loss in a clinically representative obese population.
Effect of ramipril on the incidence of diabetes.
Among persons with impaired fasting glucose levels or impaired glucose tolerance, the use of ramipril for 3 years does not significantly reduce the incidence of diabetes or death but does significantly increase regression to normoglycemia.
Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study
It is concluded that long-term intervention in the form of diet and physical exercise is feasible even on a large scale, and that substantial metabolic improvement can be achieved which may contribute to prevent or postpone manifest diabetes.